Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway.
- Published In:
- European journal of pharmacology, 1007, 178264 (2025)
- Authors:
- Han, Wentao, Dai, Shirui, Sun, Xinyue, Liu, Shaohua, Zhang, Liwei, Chen, Baihua
- Database ID:
- RPEP-11274
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11274APA
Han, Wentao; Dai, Shirui; Sun, Xinyue; Liu, Shaohua; Zhang, Liwei; Chen, Baihua. (2025). Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway.. European journal of pharmacology, 1007, 178264. https://doi.org/10.1016/j.ejphar.2025.178264
MLA
Han, Wentao, et al. "Liraglutide promotes diabetic corneal epithelial and nerve regeneration by suppressing oxidative stress via the PI3K/AKT signalling pathway.." European journal of pharmacology, 2025. https://doi.org/10.1016/j.ejphar.2025.178264
RethinkPeptides
RethinkPeptides Research Database. "Liraglutide promotes diabetic corneal epithelial and nerve r..." RPEP-11274. Retrieved from https://rethinkpeptides.com/research/han-2025-liraglutide-promotes-diabetic-corneal
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.